Stable parkinsonian syndrome and uneven loss of striatal dopamine fibres following chronic MPTP administration in baboons
Authors:
- M. VarastetMVM. Varastet
- M. PeschanskiMPM. Peschanski
- D. RicheDRD. Riche
- P. CesaroPCP. Cesaro
- J. C. WillerJWJ. C. Willer
- M. MaziereMMM. Maziere
- 1 March 1993
- journal article
- Published by Elsevier in Neuroscience
- Vol. 53 (1) , 169-178
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Nigral degeneration in Parkinson's disease in relation to clinical featuresActa Neurologica Scandinavica, 1991
- AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITYBrain, 1991
- MPTP-induced parkinsonism in monkeys: Mechanism of action, selectivity and pathophysiologyGeneral Pharmacology: The Vascular System, 1988
- Uneven Pattern of Dopamine Loss in the Striatum of Patients with Idiopathic Parkinson's DiseaseNew England Journal of Medicine, 1988
- The neurotoxicity of 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine (mptp) and its relevance to parkinson's diseaseNeurochemistry International, 1987
- MPTP and its relevance to parkinson's diseaseNeurochemistry International, 1987
- “In vivo” visualization by positron emission tomography of the progressive striatal dopamine receptor damage occuring in MPTP-intoxicated non-human primatesLife Sciences, 1986
- Hemiparkinsonism in monkeys after unilateral internal carotid artery artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)Life Sciences, 1986
- III. Primate model of parkinsonism: Selective lesion of nigrostriatal neurons by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine produces an extrapyramidal syndrome in rhesus monkeysLife Sciences, 1985
- I. Parkinson's disease: Studies with an animal modelLife Sciences, 1984